Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Economic, Clinical, and Societal Impact of Early Thromboembolic -Risk Detection in High-Risk Atrial Fibrillation: A Model -Based Evaluation of the MATHIAS Strategy.

NCT07441759 is registered in ClinicalTrials.gov with Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina as lead sponsor.

NCT NCT07441759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07441759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Economic, Clinical, and Societal Impact of Early Thromboembolic -Risk Detection in High-Risk Atrial Fibrillation: A Model -Based Evaluation of the MATHIAS Strategy.
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Phase
Observational
Overall status
Not yet recruiting
Start date
July 6, 2026
Completion date
December 31, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), atrial fibrillation (af), cardio vascular disease, cardio-cerebrovascular disease, cost-effectiveness analysis, electronic health records, mace, quality-adjusted life-years, thromboembolic risk